# Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains

> **NCT02968758** · NA · COMPLETED · sponsor: **Meridian Bioscience, Inc.** · enrollment: 2461 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DEVICE:** Comparison between GenePOC PCR and Reference Method

## Key facts

- **NCT ID:** NCT02968758
- **Lead sponsor:** Meridian Bioscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-06
- **Primary completion:** 2017-08-02
- **Final completion:** 2017-08-10
- **Target enrollment:** 2461 (ACTUAL)
- **Last updated:** 2021-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02968758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02968758, "Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02968758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*